Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Melatonin × Clear all

NCT02430298 2016-02-24

Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients

Phase 2 Completed

Head and Neck Neoplasms